GI
ZBIO

GAMMA Investing’s Zenas BioPharma ZBIO Stock Holding History

GAMMA Investing’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.95K Sell
195
-50
-20% -$994 ﹤0.01% 3474
2026
Q1 		$4.79K Buy
245
+66
+37% +$1.48K ﹤0.01% 3376
2025
Q4 		$6.5K Sell
179
-4
-2% -$132 ﹤0.01% 3168
2025
Q3 		$4.06K Buy
183
+104
+132% +$1.69K ﹤0.01% 3253
2025
Q2 		$766 Buy
79
+38
+93% +$370 ﹤0.01% 3584
2025
Q1 		$324 Buy
+41
New +$321 ﹤0.01% 3734

Other funds holding ZBIO

IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

GAMMA Investing's ZBIO Position: Q2 2026 in Review

GAMMA Investing reduced its Zenas BioPharma (ZBIO) stake by 20% in Q2 2026, selling an estimated $994 and leaving 195 shares worth $4.95K. The position accounts for ﹤0.01% of the portfolio, ranked #3474.

GAMMA Investing first reported a position in ZBIO in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.5K in Q4 2025. 17 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • GAMMA Investing held 195 shares of Zenas BioPharma worth $4.95K as of Q2 2026.
  • GAMMA Investing sold 50 Zenas BioPharma shares in Q2 2026, an estimated $994.
  • Zenas BioPharma made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3474 holding.
  • GAMMA Investing first reported a position in Zenas BioPharma in Q1 2025 and has held it in 6 quarters since.
  • GAMMA Investing's Zenas BioPharma position peaked at $6.5K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.